Skip to main content

Oxytocin manufacturing ban for domestic use to come into effect from 1st July 2018

 

Clinical courses

 

Clinical courses

The Ministry of Health and Family Welfare has restricted the manufacture of Oxytocin formulations for domestic use to public sector only from 1st July 2018. It has also banned the import of Oxytocin and its formulations.
From 1st July 2018, no private manufacturer will be allowed to manufacture the drug for domestic use.

Oxytocin is a naturally-occurring hormone that causes uterine contractions during labour and helps new mothers lactate.

However, the drug is heavily misused in the dairy industry where livestock are injected with oxytocin to make them release milk at a time convenient to farmers. The hormone is also used to increase the size of vegetables such as pumpkins, watermelons, brinjals, gourds and cucumbers.

Only Karnataka Antibiotics & Pharmaceuticals Ltd (KAPL), a public sector company, would be manufacturing this drug for domestic use from that date. The Oxytocin formulations meant for domestic consumption will be supplied by the manufacturer, i.e. KAPL, to the registered hospitals and clinics in public and private sector directly .

Oxytocin in any form or name will not be allowed to be sold through retail Chemist.

All the registered hospitals and clinics in public and private sector in the country are advised to contact KAPL and place their orders with the company as the drug will not be available with retail chemists or any other manufacturer.

<< Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email